Dr Liz Mear (Co-Chair)
CEO at Dr Liz Mear, Consultant, Chair and Coach
Chairing and facilitation plus assessment of innovation proposals.
Dr Terry Parlett (Co-Chair)
Commercialisation Director at Cambridge Enterprise Limited
Responsible for the development and commercialisation of Intellectual Property assets and research from the University of Cambridge to create new ventures, partnerships, products and services in Life Science and Health sectors. Experience also includes joint venture creation (public-private), co-development and alliancing relationships and technology licensing and held Board, Investor Director, Non-Exec and advisory roles.
Mr Tim de Winter
Deputy Director of Strategy at Homerton Healthcare NHS Foundation Trust
14 years' healthcare experience across operations, commercial, strategy, operationalisation, project/programme/change management and across public, private and government organisations.
Mr Lee Callaghan
PPIE Representative
General Counsel Group at Aviva PLC
I am a stroke survivor from 2014 when I had an ischemic stroke when 39. I represent patient interests and issues on a voluntary basis.
Professor Gary Ford
CEO at Health Innovation Oxford and Thames Valley
Consultant Physician at Oxford University Hospitals NHS Foundation Trust
Professor of Stroke Medicine at University of Oxford
Stroke care, Innovation adoption.
Dr Matthew Glover
Senior Research Fellow at University of Surrey
Health Economics, Decision Modelling, Economic Evaluation, Cost-effectiveness, Clinical Trials, Outcome Measurement
Ms Maria Heard
Deputy Director Research and Innovation at NHS Somerset ICB
Health and Care Strategy, Major Service Reconfiguration, Quality Improvement, Research and Innovation.
Dr Praveen Kumar
Associate Professor in Stroke Rehabilitation at University of the West of England, Bristol
Co-development of complex technology-based interventions (including wearable sensors, smart garments, digital apps, home sensors, gaming devices) for people with stroke and frailty from diverse backgrounds.
Mr Loy Lobo
Managing Director at Wegyanik Ltd
Digital Health, Medical Devices, Digitral Therapeutics, and multiple therapeutics areas including Cardiovascular, Metabolic, Renal, Respiratory, Neurological, and Mental Health.
Mrs Michelle Long
NSA Stroke and Therapy Lead at SRC at NHSE and University Hospitals Sussex
Neuro rehab specialist Physiotherapist, Therapy lead ona level 2a rehab unit and NSA for stroke.
Professor Deb Lowe
Consultant Stroke Physician, National Clinical Lead for Stroke GIRFT programme at NHSE
Medical Director at The Stroke Association
QI, influencing and policy across stroke pathway.
Professor Stephen Morris
RAND Professor of Health Services Research at University of Cambridge
Health economics, health services research.
Dr Dan Mullarkey
Medical Director at Skin Analytics Ltd
NHS GP at Hetherington Group Practice
Dr. Dan Mullarkey is a recognised clinical leader who has balanced his role as a GP in South London with industry positions focused on validating and deploying digital health technologies, including AI as a Medical Device (AIaMD).
Dr James Rose
Director of Strategic and Industry Partnerships at Health Innovation Oxford and Thames Valley
Adoption, Spread, Reimbursement, HT, Health Economics. Market Access, Respiratory medicine.
Ms Annabel Wright
PPIE Representative
Young Stroke Survivor and member of The Stroke Association - Stroke Voices in Research.